Prevention Of Disulfide Bond Reduction During Recombinant Production Of Polypeptides - EP3597659

The patent EP3597659 was granted to Genentech on Mar 1, 2023. The application was originally filed on Jul 8, 2008 under application number EP19181777A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3597659

GENENTECH
Application Number
EP19181777A
Filing Date
Jul 8, 2008
Status
Granted And Under Opposition
Jan 27, 2023
Grant Date
Mar 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ICOSADec 1, 2023ADMISSIBLE
KRAUS & LEDERER PARTGMBBDec 1, 2023ADMISSIBLE
MABXIENCE RESEARCHDec 1, 2023ADMISSIBLE
MERCK SHARP & DOHMEDec 1, 2023ADMISSIBLE
HOFFMANN EITLENov 30, 2023ADMISSIBLE
MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBBNov 30, 2023ADMISSIBLE
STRAWMANNov 29, 2023ADMISSIBLE
OETKENov 28, 2023ADMISSIBLE
BROCHERNov 20, 2023ADMISSIBLE

Patent Citations (120) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO1998US13410-
DESCRIPTIONEP0139383
DESCRIPTIONEP0183070
DESCRIPTIONEP0244234
DESCRIPTIONEP0307247
DESCRIPTIONEP0394538
DESCRIPTIONEP0402226
DESCRIPTIONEP0404097
DESCRIPTIONEP0420937
DESCRIPTIONUS2002006404
DESCRIPTIONUS2002009444
DESCRIPTIONUS2002012665
DESCRIPTIONUS2002058029
DESCRIPTIONUS2002128488
DESCRIPTIONUS2002197255
DESCRIPTIONUS2003021781
DESCRIPTIONUS2003082172
DESCRIPTIONUS2003095963
DESCRIPTIONUS2003103971
DESCRIPTIONUS2003147885
DESCRIPTIONUS4515893
DESCRIPTIONUS4560655
DESCRIPTIONUS4657866
DESCRIPTIONUS4767704
DESCRIPTIONUS4816567
DESCRIPTIONUS4927762
DESCRIPTIONUS4943529
DESCRIPTIONUS5091313
DESCRIPTIONUS5122469
DESCRIPTIONUS5545806
DESCRIPTIONUS5545807
DESCRIPTIONUS5569825
DESCRIPTIONUS5622700
DESCRIPTIONUS5625126
DESCRIPTIONUS5633425
DESCRIPTIONUS5639635
DESCRIPTIONUS5661016
DESCRIPTIONUS5672347
DESCRIPTIONUS5693762
DESCRIPTIONUS5714338
DESCRIPTIONUS5721108
DESCRIPTIONUS5721121
DESCRIPTIONUS5725856
DESCRIPTIONUS5736137
DESCRIPTIONUS5776456
DESCRIPTIONUS5807715
DESCRIPTIONUS5843439
DESCRIPTIONUS5854067
DESCRIPTIONUS6171586
DESCRIPTIONUS6194551
DESCRIPTIONUS6242195
DESCRIPTIONUS6399061
DESCRIPTIONUS6455043
DESCRIPTIONUS6528624
DESCRIPTIONUS6538124
DESCRIPTIONUS7169908
DESCRIPTIONUSRE30985E
DESCRIPTIONWO0009160
DESCRIPTIONWO0027428
DESCRIPTIONWO0027433
DESCRIPTIONWO0042072
DESCRIPTIONWO0044788
DESCRIPTIONWO0067796
DESCRIPTIONWO0075348
DESCRIPTIONWO0110460
DESCRIPTIONWO0110461
DESCRIPTIONWO0110462
DESCRIPTIONWO0140309
DESCRIPTIONWO0174388
DESCRIPTIONWO0180884
DESCRIPTIONWO0197858
DESCRIPTIONWO0204021
DESCRIPTIONWO02060955
DESCRIPTIONWO02079255
DESCRIPTIONWO02096948
DESCRIPTIONWO0234790
DESCRIPTIONWO03056012
DESCRIPTIONWO03064621
DESCRIPTIONWO8700195
DESCRIPTIONWO9003430
DESCRIPTIONWO9100357
DESCRIPTIONWO9110741
DESCRIPTIONWO9301161
DESCRIPTIONWO9304173
DESCRIPTIONWO9519181
DESCRIPTIONWO9523865
DESCRIPTIONWO9630046
DESCRIPTIONWO9633735
DESCRIPTIONWO9634096
DESCRIPTIONWO9640210
DESCRIPTIONWO9726912
DESCRIPTIONWO9806248
DESCRIPTIONWO9823761
DESCRIPTIONWO9824893
DESCRIPTIONWO9845331
DESCRIPTIONWO9851793
DESCRIPTIONWO9856418
DESCRIPTIONWO9858964
DESCRIPTIONWO9922764
DESCRIPTIONWO9951642
OPPOSITIONEP0185459
OPPOSITIONEP2188302
OPPOSITIONUS2004138424
OPPOSITIONUS2006142549
OPPOSITIONUS2006216790
OPPOSITIONUS4572798
OPPOSITIONUS5808006
OPPOSITIONUS6590072
OPPOSITIONWO0220818
OPPOSITIONWO2005016968
OPPOSITIONWO2006034488
OPPOSITIONWO2006047340
OPPOSITIONWO2009009523
OPPOSITIONWO9726357
OTHEREP2188302
OTHEREP2586788
OTHERUS8574869
SEARCHUS2004138424
SEARCHUS2006142549
SEARCHWO9726357

Non-Patent Literature (NPL) Citations (233) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- Advances in Immunology-
DESCRIPTION- Annual Review of Immunology-
DESCRIPTION- ARTEAGA et al., Cancer Res., (19940000), vol. 54, pages 3758 - 3765-
DESCRIPTION- ARUFFO et al., Cell, (19900000), vol. 61, pages 1303 - 1313-
DESCRIPTION- BABSON, A.L.BABSON, S.R., "Kinetic Colorimetric Measurement of Serum Lactate Dehydrogenase Activity", Clin. Chem., (19730000), vol. 19, pages 766 - 769, XP009119838-
DESCRIPTION- BACUS et al., Cancer Research, (19920000), vol. 52, pages 2771 - 2776-
DESCRIPTION- BACUS, Molecular Carcinogenesis, (19900000), vol. 3, pages 350 - 362-
DESCRIPTION- BALLANCE et al., Biochem. Biophys. Res. Commun., (19830000), vol. 112, page 284 289-
DESCRIPTION- BARBAS, Proc Nat. Acad. Sci. USA, (19940000), vol. 91, pages 3809 - 3813-
DESCRIPTION- BARNESSATO, Anal. Biochem., (19800000), vol. 102, page 255-
DESCRIPTION- BASELGA et al., J Clin. Oncol., (19960000), vol. 14, pages 737 - 744-
DESCRIPTION- BASS et al., Proteins, (19900000), vol. 8, pages 309 - 314-
DESCRIPTION- BEACHNURSE, Nature, (19810000), vol. 290, pages 140 - 681-
DESCRIPTION- BRENNAN et al., Science, (19850000), vol. 229, page 81-
DESCRIPTION- BRODEUR et al., Monoclonal Antibody Production Techniques and Applications, American Society for Microbiology, (19870000), vol. 2, pages 1190 - 1219-
DESCRIPTION- BRUGGEMANN, Year in Immunol., (19930000), vol. 7, page 33-
DESCRIPTION- BRUGGERMANN et al., Year in Immuno., (19930000), vol. 7, page 33-
DESCRIPTION- C. ANTHONY, The Biochemistry of Methylotrophs, (19820000), vol. 269-
DESCRIPTION- CARTER et al., Bio/Technology, (19920000), vol. 10, pages 163 - 167-
DESCRIPTION- CARTER et al., Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 4285 - 4289-
DESCRIPTION- CASE et al., Proc. Natl. Acad. Sci. USA, (19790000), vol. 76, page 5259 5263-
DESCRIPTION- CHADERJIAN et al., Biotechnol. Prog., (20050000), vol. 21, no. 2, pages 550 - 3-
DESCRIPTION- CHADERJIAN, W.B.CHIN, E.T.HARRIS, R.J.ETCHEVERRY, T.M., "Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed", Biotechnol. Prog., (20050000), vol. 21, pages 550 - 553-
DESCRIPTION- CHOY, Arthritis Rheum, (19960000), vol. 39, no. 1, pages 52 - 56-
DESCRIPTION- CLACKSON et al., Nature, (19910000), vol. 352, pages 624 - 628-
DESCRIPTION- DEMIDEM et al., Cancer Chemotherapy & Radiopharmaceuticals, (19970000), vol. 12, no. 3, pages 177 - 186-
DESCRIPTION- DEVITA et al., "Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis", Arthritis & Rheumatism, (20020000), vol. 46, pages 2029 - 2033-
DESCRIPTION- DHAINAUT et al., Crit. Care Med., (19950000), vol. 23, no. 9, pages 1461 - 1469-
DESCRIPTION- DUCHOSAL et al., Nature, (19920000), vol. 355, page 258-
DESCRIPTION- EDWARDS et al., "Efficacy and safety of Rituximab, a B-cell targeted chimeric monoclonal antibody: A randomized, placebo controlled trial in patients with rheumatoid arthritis", Arthritis & Rheumatism, (20020000), vol. 46, no. 9, page 197-
DESCRIPTION- FAHRNER et al., Biotechnol. Genet. Eng. Rev., (20010000), vol. 18, pages 301 - 27-
DESCRIPTION- FELLOUSE, Proc. Natl. Acad. Sci. USA, (20040000), vol. 101, no. 34, pages 12467 - 12472-
DESCRIPTION- FISHWILD et al., Nature Biotechnol., (19960000), vol. 14, pages 826 - 851-
DESCRIPTION- FLEER et al., Bio/Technology, (19910000), vol. 2, page 968 975-
DESCRIPTION- FLOOGENBOOM et al., J. Mol. Biol., (19910000), vol. 227, pages 381 - 597-
DESCRIPTION- GODING, Monoclonal Antibodies: Principles and Practice, Academic Press, (19860000), pages 59 - 103-
DESCRIPTION- GRAHAM et al., J. Gen Virol., (19770000), vol. 36, page 59-
DESCRIPTION- GRAZIANO et al., J. Immunot., (19950000), vol. 155, no. 10, pages 4996 - 5002-
DESCRIPTION- GRUBER et al., J. Immunol., (19940000), vol. 152, page 5368-
DESCRIPTION- HAMMES G.G.KOCHAVI D., "Studies of the Enzyme Hexokinase. III. The Role of the Metal Ion", J. Am. Chem. Soc., (19620000), vol. 84, pages 2076 - 2079-
DESCRIPTION- HAMMES G.G.KOCHAVI D., "Studies of the Enzyme Hexokinase. I. Steady State Kinetics at pH 8", J. Am. Chem. Soc., (19620000), vol. 84, pages 2069 - 2073-
DESCRIPTION- HAMS, Biochem. Soc. Transactions, (19950000), vol. 23, pages 1035 - 1038-
DESCRIPTION- HAMWALLACE, Meth. in Enz., (19790000), vol. 58, page 44-
DESCRIPTION- HANCOCK et al., Cancer Res., (19910000), vol. 51, pages 4575 - 4580-
DESCRIPTION- HARWERTH et al., J. Biol. Chem., (19920000), vol. 267, pages 15160 - 15167-
DESCRIPTION- HAWKINS et al., J. Mol. Biol., (19920000), vol. 226, pages 889 - 896-
DESCRIPTION- HOOGENBOOM et al., Mol. Immunol., (19910000), vol. 28, pages 1027 - 1037-
DESCRIPTION- HOURMANT, Transplantation, (19940000), vol. 113, pages 37 55 - 380-
DESCRIPTION- HUDSON et al., Nat. Med., (20030000), vol. 9, pages 129 - 134-
DESCRIPTION- HURLEGROSS, Curr. Op. Biotech., (19940000), vol. 5, pages 428 - 433-
DESCRIPTION- JACKSON et al., J. Immunol., (19950000), vol. 155, no. 2, pages 3310 - 2004-
DESCRIPTION- JAKOBOVITS et al., Nature, (19930000), vol. 362, pages 255 - 258-
DESCRIPTION- JAKOBOVITS et al., Proc. Natl. Acad. Sci. USA, (19930000), vol. 90, pages 6444 - 6448-
DESCRIPTION- JOHN C. JOLY et al., "Overexpression of Eschericia coli Oxidoreductases Increases Recombinant Insulin-like Growth Factor-I Accumulation", Proc. Natl. Acad. Sci. USA, (19980300), vol. 95, pages 2773 - 2777-
DESCRIPTION- JONES et al., Nature, (19860000), vol. 321, pages 522 - 525-
DESCRIPTION- JUWEID et al., Cancer Res, (19950000), vol. 55, no. 23, pages 5899s - 5907s-
DESCRIPTION- KELLYHYNES, EMBO J., (19850000), vol. 4, page 475 479-
DESCRIPTION- KIM et al., Growth Factors, (19920000), vol. 7, pages 53 - 64-
DESCRIPTION- KIPRIYANOVLITTLE, Molecular Biotechnology, (19990000), vol. 12, page 173 201-
DESCRIPTION- KIRKPATRICK D.L.WATSON S.KUNKEL M.FLETCHER S.ULHAQ S.POWIS G., "Parallel syntheses of disulfide inhibitors of the Trx redox system as potential antitumor agents", Anticancer Drug Des., (19990000), vol. 14, pages 421 - 432-
DESCRIPTION- KLAPPER et al., Oncogene, (19970000), vol. 14, pages 2099 - 2109-
DESCRIPTION- KOHLER et al., Nature, (19750000), vol. 256, page 495-
DESCRIPTION- KOSTELNY et al., J. Immunol., (19920000), vol. 148, no. 5, pages 1547 - 1553-
DESCRIPTION- KOZBOR, J Immunol., (19840000), vol. 133, page 3001-
DESCRIPTION- LAURA C. SIMMONS, "Expression of Full-length Immunoglobulins in Escherichia coli: Rapid and Efficient Production of Aglycosylated Antibodies", Journal of Immunological Methods, (20020000), vol. 263, pages 133 - 147-
DESCRIPTION- LEANDRO et al., "Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion", Ann Rheum Dis, (20020000), vol. 61, pages 833 - 888-
DESCRIPTION- LEANDRO et al., "Lymphocyte depletion in rheumatoid arthritis: early evidence for safety, efficacy and dose response", Arthritis & Rheumatism, (20010000), vol. 44, no. 9, page S370-
DESCRIPTION- LEE et al., J. Immunol. Methods, (20040000), vol. 284, no. 1-2, pages 119 - 132-
DESCRIPTION- LEHRNBECHER et al., Blood, (19990000), vol. 94, page 4220-
DESCRIPTION- LEVINEPESTRONK, "IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab", Neurology, (19990000), vol. 52, pages 1701 - 1704, XP000942610-
DESCRIPTION- LITTON et al., Eur J. Immunol., (19960000), vol. 26, no. 1, pages 1 - 9-
DESCRIPTION- LONBERG et al., Nature, (19940000), vol. 368, pages 812 - 813-
DESCRIPTION- LONBERGHUSZAR, Intern. Rev. Immunol., (19950000), vol. 13, pages 65 - 93-
DESCRIPTION- LORENZ et al., J. Immunol., (19960000), vol. 156, no. 4, pages 1646 - 1653-
DESCRIPTION- LOUVENCOURT et al., J. Bacteriol., (19830000), vol. 737-
DESCRIPTION- MALONEY et al., Blood, (19960000), vol. 88, no. 10, page 637a-
DESCRIPTION- MARKS et al., BioTechnology, (19920000), vol. 10, pages 779 - 783-
DESCRIPTION- MARKS et al., Technology, (19920000), vol. 10, pages 779 - 783-
DESCRIPTION- MATHER, Biol. Reprod., (19800000), vol. 23, pages 243 - 251-
DESCRIPTION- MATHER et al., Annals N. Y. Acad Sci., (19820000), vol. 383, pages 44 - 68-
DESCRIPTION- MCCAFFERTY et al., Nature, (19900000), vol. 348, pages 552 - 554-
DESCRIPTION- MCKENZIE et al., Oncogene, (19890000), vol. 4, pages 543 - 548-
DESCRIPTION- MICHAEL W. LAIRD, "Optimization of BLyS Production and Purification from Eschericia coli", Protein Expression and Purification, (20050000), vol. 39, pages 237 - 246-
DESCRIPTION- MILHAUSEN, M.LEVY, H.R., "Evidence for an Essential Lysine in G6PD from Leuconostoc mesenteroides", Eur. J. Biochem., (19750000), vol. 50, pages 453 - 461, XP055515265-
DESCRIPTION- MILLSTEIN, Nature, (19830000), vol. 305, pages 537 - 539-
DESCRIPTION- MORIMOTO et al., Journal of Biochemical and Biophysical Methods, (19920000), vol. 24, pages 107 - 117-
DESCRIPTION- MORRISON et al., Proc. Natl Acad. Sci. USA, (19840000), vol. 81, page 6851-
DESCRIPTION- MORRISON et al., Proc. Natl. Acad. Sci. USA, (19840000), vol. 81, pages 1470 1474 - 6855-
DESCRIPTION- NIWA R. et al., Cancer Res., (20040000), vol. 64, no. 6, pages 2127 - 2133-
DESCRIPTION- PEROTTAABUEL, "Response of chronic relapsing ITP of 10 years duration to Rituximab", Blood, (19980000), vol. 10, no. l, page 88B-
DESCRIPTION- PLEASANTS, J.C.GUO, W.RABENSTEIN, D.L., "A comparative study of the kinetics of selenol/diselenide and thiol/disulfide exchange reactions", J. Am. Chem. Soc., (19890000), vol. 111, pages 6553 - 6558, XP055518635-
DESCRIPTION- PRESTA, Curr. Op. Struct. Biol., (19920000), vol. 2, pages 593 - 596-
DESCRIPTION- PRESTA et al., J. Immnol., (19930000), vol. 151, page 2623-
DESCRIPTION- PRESTA, J. Immunot., (19930000), vol. 151, pages 2623 - 2632-
DESCRIPTION- REFF et al., Blood, (19940000), vol. 83, no. 2, pages 435 - 445-
DESCRIPTION- RICHMAN et al., Cancer Res., (19950000), vol. 55, no. 23, pages 5916s - 5920s-
DESCRIPTION- RIECHMANN et al., Nature, (19880000), vol. 332, pages 323 - 327-
DESCRIPTION- SARWAL et al., N. Eng. J. Med., (20030710), vol. 349, no. 2, pages 125 - 138-
DESCRIPTION- SCHIER et al., Gene, (19950000), vol. 169, pages 147 - 155-
DESCRIPTION- SHALABY et al., J. Exp. Med., (19920000), vol. 175, pages 217 - 225-
DESCRIPTION- SHINKAWA et al., J Bio. Chem., (20030000), vol. 278, no. 5, pages 3466 - 347-
DESCRIPTION- SHI Y., Trends in Genetics, (20030000), vol. 19, no. 1, pages 9 - 12-
DESCRIPTION- SIDHU et al., J. Mol. Biol., (20040000), vol. 340, no. 5, pages 1073 - 1093-
DESCRIPTION- SIMS et al., J. Immunol., (19930000), vol. 151, page 2296-
DESCRIPTION- SREEKRISHNA et al., J. Basic Microbiol., (19880000), vol. 28, page 265 278-
DESCRIPTION- STAMENKOVIC, Cell, (19910000), vol. 66, pages 1133 - 1144-
DESCRIPTION- STANCOVSKI et al., PNAS (USA), (19910000), vol. 88, pages 8691 - 8695-
DESCRIPTION- STASHI et al., "Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idopathic thrombocytopenic purpura", Blood, (20010000), vol. 98, no. 4, pages 952 - 957-
DESCRIPTION- STEPPE et al., Transplant Intl., (19910000), vol. 4, pages 3 - 7-
DESCRIPTION- ST JOHN et al., Chest, (19930000), vol. 103, page 932-
DESCRIPTION- TAGLIABUE et al., Int. J. Cancer, (19910000), vol. 47, pages 933 - 937-
DESCRIPTION- TILBURN et al., Gene, (19830000), vol. 26, page 205 221-
DESCRIPTION- TRAUNECKER et al., EMBO J, (19910000), vol. 10, pages 3655 - 3659-
DESCRIPTION- TUTT et al., J. Immunol., (19910000), vol. 147, page 60-
DESCRIPTION- URLAUB et al., Proc. Natl. Acad. Sci. USA, (19800000), vol. 77, page 4216-
DESCRIPTION- VAN DEN BERG et al., Bio/Technology, (19900000), vol. 8, page 135-
DESCRIPTION- VASWANIHAMILTON, Ann. Allergy, Asthma & Immunol., (19980000), vol. 1, pages 105 - 115-
DESCRIPTION- VAUGHAN et al., Nature Biotech, (19960000), vol. 14, page 309-
DESCRIPTION- VERHOEYEN et al., Science, (19880000), vol. 239, pages 1038 1040 - 1536-
DESCRIPTION- WATERHOUSE, Nuc. Acids. Res., (19930000), vol. 21, pages 2265 - 2266-
DESCRIPTION- WHITESIDES, G.M.LILBURN, J.E.SZAJEWSKI, R.P., "Rates of thioldisulfide interchange reactions between mono- and dithiols and Ellman's reagent", J. Org. Chem., (19770000), vol. 42, pages 332 - 338-
DESCRIPTION- WIPF P.HOPKINS T.D.LUNG J.K.RODRIGUEZ S.BIRMINGHAM A.SOUTHWICK E.C.LAZO J.S.POWIS G, "New inhibitors of the Trx-TrxR system based on a naphthoquinone spiroketal natural product lead", Bioorg. Med. Chem. Lett., (20010000), vol. 11, pages 2637 - 2641-
DESCRIPTION- XU et al., Int. J. Cancer, (19930000), vol. 53, pages 401 - 408-
DESCRIPTION- "Yeast Hexokinase : ATP + Hexose --> Hexose-6-phosphate + ADP", WIRTH M.HAUSER H., Methods in Enzymology, Academic Press, Inc., (19550000), vol. 1, pages 269 - 276-
DESCRIPTION- ZAPATA et al., Protein Eng., (19950000), vol. 8, no. 10, pages 1057 - 1062-
DESCRIPTION- LEANDRO, "An open study of B lymphocyte depletion in systemic lupus erythematosus", Arthritis & Rheumatism, (20020000), vol. 46, no. 1, doi:10.1002/art.10541, pages 2673 - 2677, XP002378313
DESCRIPTION- GROMER S.URIG S.BECKER K., "TheTrx System - From Science to Clinic", Medicinal Research Reviews, (20040000), vol. 24, doi:10.1002/med.10051, pages 40 - 89, XP002694209
DESCRIPTION- GORDON G.MACKOW M.C.LEVY H.R., "On the mechanism of interaction of steroids with human glucose 6-phosphate dehydrogenase", Arch. Biochem. Biophys., (19950000), vol. 318, doi:10.1006/abbi.1995.1199, pages 25 - 29, XP055514709
DESCRIPTION- SOLS, A.DELAFUENTE, G.VILLAR-PALASI, C.ASENSIO, C., "Substrate Specificity and Some Other Properties of Bakers' Yeast Hexokinase", Biochim Biophys Acta, (19580000), vol. 30, doi:10.1016/0006-3002(58)90245-2, pages 92 - 101, XP023378283
DESCRIPTION- LEGRAND, C.BOUR, J.M.JACOB, C.CAPIAUMONT J.MARTIAL, A.MARC, A.WUDTKE, M.KRETZMER, G.DEMANGEL, C.DUVAL, D., "Lactate Dehydrogenase (LDH) Activity of the Number of Dead Cells in the Medium of Cultured Eukaryotic Cells as Marker", J. Biotechnol., (19920000), vol. 25, doi:10.1016/0168-1656(92)90158-6, pages 231 - 243, XP024346496
DESCRIPTION- DANA C. ANDERSEN et al., "Production Technologies for Monoclonal Antibodies and Their Fragments", Current Opinion in Biotechnology, (20040000), vol. 15, doi:10.1016/j.copbio.2004.08.002, pages 456 - 462, XP004588033
DESCRIPTION- KIRKPATRICK D.L.KUPERUS M.DOWDESWELL M.POTIER N.DONALD L.J.KUNKEL M.BERGGREN M.ANGULO M.POWIS G., "Mechanisms of inhibition of the Trx growth factor system by antitumor 2-imidazolyl disulfides", Biochem. Pharmacol., (19980000), vol. 55, doi:10.1016/S0006-2952(97)00597-2, pages 987 - 994, XP002979943
DESCRIPTION- YARIV MAZOR, "Isolation of Engineered, Full-length Antibodies from Libraries Expressed in Escherichia coli", Nature Biotech., (20070601), vol. 25, doi:10.1038/nbt1296, pages 563 - 565, XP002488027
DESCRIPTION- EDWARDS et al., "B-lymphocyte depletion therapy in rheumatoid arthritis and other autoimmune disorders", Biochem. Soc. Trans., (20020000), vol. 30, no. 4, doi:10.1042/BST0300824, pages 824 - 828, XP002306250
DESCRIPTION- PAUL H. BESSETTE et al., "Efficient Folding of Proteins with Multiple Disulfide Bonds in the Escherichia coli cytoplasm", Proc. Natl. Acad. Sci., (19990000), vol. 96, no. 24, doi:10.1073/pnas.96.24.13703, pages 13703 - 08, XP002233564
DESCRIPTION- JOHANSSON C.LILLIG C.H.HOLMGREN A., "Human Mitochondrial Glutaredoxin Reduces S-Glutathionylated Proteins with High Affinity Accepting Electrons from Either Glutathione or Thioredoxin Reductase", J. Biol. Chem., (20040000), vol. 279, doi:10.1074/jbc.M312719200, pages 7537 - 7543, XP055514721
DESCRIPTION- EDWARDSCAMBRIDGE, "Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes", Rheumatology, (20010000), vol. 40, doi:10.1093/rheumatology/40.2.205, pages 205 - 211, XP002348931
OPPOSITION- Anonymous, "Dulbecco’s Modified Eagle’s Medium/ Ham’s Nutrient Mixture F12 - Product Information", SAFC Biosciences™, (20061201), SAFC Biosciences™, (20240402), XP093147247-
OPPOSITION- Anonymous, "Orencia - Scientific discussion", European Medicines Agency, (20070101), European Medicines Agency, (20240402), XP093147239-
OPPOSITION- Anonymous, "PRODUCTION AND QUALITY CONTROL OF MONOCLONAL ANTIBODIES", European Medicines Agency, (19950701), pages 237 - 262, European Medicines Agency, URL: https://www.ema.europa.eu/en/documents/scientific-guideline/production-and-quality-control-monoclonal-antibodies_en.pdf, (20240402), XP093147245-
OPPOSITION- Anonymous, "SUMMARY BASIS FOR APPROVAL: Drug License Name: Interferon beta-la / Drug Trade Name: AVONEXTM ", FDA, (19960101), XP093170403-
OPPOSITION- Anonymous, "Therapeutic monoclonal antibodies approved in the EU or US as of Dec 2023 ", the antibody society, (20231201), the antibody society , XP093170615-
OPPOSITION- Anonymous, "Zeta Plus Depth Filtration and Alternative Technologies for Cell Culture Clarification ", Bioprocess, Biologicals, & Pharmaceutical, (20020401), pages 1 - 8, XP093148309-
OPPOSITION- Anonymous, "Zeta Plus® Depth Filtration and Alternative Technologies for Cell Culture Clarification", CUNO, (20020401), CUNO, URL: https://multimedia.3m.com/mws/media/418849O/zeta-plus-depth-filtration-for-cell-culture-clarification.pdf, (20240402), XP093147241-
OPPOSITION- Bardwell James C-A, "Disulfide Bond Formation, a Race between FAD and Oxygen", Developmental Cell, (20020101), vol. 3, no. 6, pages 758 - 760, XP093148351-
OPPOSITION- Butler Michael, "Cell line development and culture strategies: future prospects to improve yields", Butler Michael, Michael Butler, Cell Culture and Upstream Processing, Taylor & Francis Group, (20070101), pages 3 - 15, ISBN 978-0-415-39969-2, XP093148307-
OPPOSITION- Butler Michael, "Cell line development and culture strategies: future prospects to improve yields", Butler Michael, Michael Butler, Cell Culture and Upstream Processing, Taylor & Francis Group, (20070101), pages 3 - 15, XP093148307-
OPPOSITION- Butler Michael, "Cell line development and culture strategies: future prospects to improve yields", Cell Culture and Upstream Processing, Taylor & Francis Group, (20070101), pages 3 - 15, XP093148307-
OPPOSITION- D92: T2605/22 decision-
OPPOSITION- "Dulbecco s Modified Eagle s Medium/Ham s Nutrient Mixture F12", Product Information, (20061201), XP009165985-
OPPOSITION- Fahey Catherese, "Investigation of Largescale Production and Quantification Methodology of Monoclonal Antibodies (MAbs)", Thesis, (20020101), pages 1 - 309, XP093146569-
OPPOSITION- Howe, Christopher, "Chapter 9.9: Mammals", Howe, Christopher, Howe, Christopher, Gene cloning and manipulation, Cambridge University Press, (19970101), pages 179 - 194, ISBN 0 521 40341 3, XP009554716-
OPPOSITION- Jayapal Et Al., "Recombinant Protein Therapeutics from CHO Cells -- 20 Years and Counting", CHO consortium, SBE Special Section, (20071001), pages 40 - 47, XP055254248-
OPPOSITION- Karthik P. Jayapal, Katie F. Wlaschin, Wei Shou Hu, Miranda G S Yap., "Recombinant Protein Therapeutics from CHO Cells -- 20 Years and Counting", CHO consortium, SBE Special Section, (20071001), pages 40 - 47, XP055254248-
OPPOSITION- Michael Butler, "Chapter 9: Scaling up animal cell culture", Michael Butler, Michael Butler, Animal Cell Culture and Technology Second Edition, BIOS Scientific Publishers , (20040101), pages 175 - 199, ISBN 978-0-203-42783-5, XP009553154-
OPPOSITION- Michael Butler, "Sealing up animal cell culture", Animal Cell Culture and Technology Second Edition, BIOS Scientific Publishers , (20040101), page 183, ISBN 978-0-203-42783-5, XP055515374-
OPPOSITION- R K Finn, "Agitation-Aeration in the laboratory and in industry", Finn Bacteriol Rev, (19540101), pages 254 - 274, XP055515363-
OPPOSITION- R K Finn, "Agitation-Aeration in the laboratory and in industry", Finn Bacteriol Rev., (19540101), pages 254 - 274, XP055515363-
OPPOSITION- R K Finn, "AGITATION-AERATION IN THE LABORATORY AND IN INDUSTRY", Finn Bacteriol Rev., (19540101), pages 254 - 274, XP055515363-
OPPOSITION- Shuichi Aiba; Arthur E. Humphrey; Nancy F. Millis, "Chapter 11 Equipment Design and Asepsis", Shuichi Aiba; Arthur E. Humphrey; Nancy F. Millis, Shuichi Aiba; Arthur E. Humphrey; Nancy F. MillisAcad. Press, Biochemical engineering, US, Acad. Press, (19730101), pages 303 - 316, ISBN 0-12-045052-6, XP009553029-
OPPOSITION- Shuichi Aiba; Arthur E. Humphrey; Nancy F. Millis, "Chapter 6 Aeration and Agitation", Biochemical engineering, US, Acad. Press, (19730101), pages 163 - 194, ISBN 0-12-045052-6, XP009553030-
OPPOSITION- Yuan Ying Jin, "Passage", Yuan Ying Jin, YUAN Yingjin, ZHAO Guangrong, FENG Xia, CHENG Chibin, Modern Pharmaceutical Technology - Volume 1, Beijing, Chemical Industry Press, (20040101), pages 343 - 344, ISBN 7-5025-5029-1, XP009553096-
OPPOSITION- Danny Chee Furng Wong; Kathy Tin Kam Wong; Peter Morin Nissom; Chew Kiat Heng; Miranda Gek Sim Yap, "Targeting early apoptotic genes in batch and fed‐batch CHO cell cultures", Biotechnology and Bioengineering, Hoboken, USA, (20060807), vol. 95, no. 3, doi:10.1002/bit.20871, ISSN 0006-3592, pages 350 - 361, XP071165953
OPPOSITION- Danny Chee Furng Wong; Kathy Tin Kam Wong; Peter Morin Nissom; Chew Kiat Heng; Miranda Gek Sim Yap, "Targeting early apoptotic genes in batch and fed‐batch CHO cell cultures", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20060807), vol. 95, no. 3, doi:10.1002/bit.20871, ISSN 0006-3592, pages 350 - 361, XP071165953
OPPOSITION- Wong Danny Chee Furng, Wong Kathy Tin Kam, Nissom Peter Morin, Heng Chew Kiat, Yap Miranda Gek Sim, "Targeting early apoptotic genes in batch and fed-batch CHO cell cultures", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20061020), vol. 95, no. 3, doi:10.1002/bit.20871, ISSN 0006-3592, pages 350 - 361, XP055854119
OPPOSITION- Melody Trexler‐Schmidt; Sandy Sargis; Jason Chiu; Stefanie Sze‐Khoo; Melissa Mun; Yung‐Hsiang Kao; Michael W. Laird, "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", Biotechnology and Bioengineering, Hoboken, USA, (20100222), vol. 106, no. 3, doi:10.1002/bit.22699, ISSN 0006-3592, pages 452 - 461, XP071155447
OPPOSITION- Trexler-Schmidt, "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", Biotechnology and Bioengineering, (2010), vol. 106, doi:10.1002/BIT.22699, XP002694206
OPPOSITION- Trexler-Schmidt M, Sargis S, Chiu J, Sze-Khoo S, Mun M, Kao YH, Laird M W, "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20100615), vol. 106, no. 3, doi:10.1002/BIT.22699, ISSN 0006-3592, pages 452 - 461, XP002694206
OPPOSITION- Kao, "Mechanism of antibody reduction in cell culture production processes", Biotechnology and Bioengineering, (2010), vol. 107, doi:10.1002/bit.22848, XP002694207
OPPOSITION- Kao Y et al., "Mechanism of Antibody Reduction in Cell Culture Production Processes", Biotechnology and Bioengineering, (20101104), vol. 107, doi:10.1002/bit.22848, XP002694207
OPPOSITION- Kao Y H, Hewitt D P, Trexler-Schmidt M, Laird M W., "Mechanism of Antibody Reduction in Cell Culture Production Processes", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (20101101), vol. 107, no. 4, doi:10.1002/bit.22848, ISSN 0006-3592, pages 622 - 632, XP002694207
OPPOSITION- Mun, "Air sparging for prevention of antibody disulfide bond reduction in harvested CHO cell culture fluid", Biotechnology and Bioengineering, (2015), vol. 112, doi:10.1002/bit.25495, XP055487175
OPPOSITION- M. P. Backer, L. S. Metzger, P. L. Slaber, K. L. Nevitt, G. B. Boder, "Large-scale production of monoclonal antibodies in suspension culture", Biotechnology and Bioengineering, Hoboken, USA, (19881005), vol. 32, no. 8, doi:10.1002/bit.260320807, ISSN 0006-3592, pages 993 - 1000, XP055315406
OPPOSITION- M. P. Backer, L. S. Metzger, P. L. Slaber, K. L. Nevitt, G. B. Boder, "Large-scale production of monoclonal antibodies in suspension culture", Biotechnology and Bioengineering, John Wiley, Hoboken, USA, Hoboken, USA, (19881005), vol. 32, no. 8, doi:10.1002/bit.260320807, ISSN 0006-3592, pages 993 - 1000, XP055315406
OPPOSITION- Wong Wei , Satish Singh , David L Zeng , Kevin King , Sandeep Nema, "Antibody structure , instability and formulation", Journal of Pharmaceutical Sciences, US , (20070101), vol. 96, no. 1, doi:10.1002/jps.20727, ISSN 0022-3549, pages 1 - 26, XP009084505
OPPOSITION- Gromer S, Urig S, Becker K., "The thioredoxin system: From science to clinic.", Medicinal research reviews, US , (20040101), vol. 24, no. 1, doi:10.1002/med.10051 , ISSN 0198-6325, pages 40 - 89, XP002694209
OPPOSITION- Gromer S, Urig S, Becker K., "The thioredoxin system: From science to clinic.", MEDICINAL RESEARCH REVIEWS, Wiley Subscription Services, Inc., A Wiley Company, US, US , (20040101), vol. 24, no. 1, doi:10.1002/med.10051 , ISSN 0198-6325, pages 40 - 89, XP002694209
OPPOSITION- Teilum, K. Ostergaard, L. Welinder, K.G., "Disulfide Bond Formation and Folding of Plant Peroxidases Expressed as Inclusion Body Protein in Escherichia coli Thioredoxin Reductase Negative Strains", Protein Expression and Purification, ACADEMIC PRESS, SAN DIEGO, CA., SAN DIEGO, CA. , (19990201), vol. 15, no. 1, doi:10.1006/prep.1998.0985, ISSN 1046-5928, pages 77 - 82, XP004441744
OPPOSITION- Raphael Levy, Robert Weiss, Gang Chen, Brent L. Iverson, George Georgiou, "Production of Correctly Folded Fab Antibody Fragment in the Cytoplasm of Escherichia coli trxB gor Mutants via the Coexpression of Molecular Chaperones", Protein Expression and Purification, Academic Press, (20011101), vol. 23, no. 2, doi:10.1006/prep.2001.1520, ISSN 10465928, pages 338 - 347, XP055024235
OPPOSITION- Kemp Glenn, Paul O'neil , "Large-scale production of therapeutic antibodies : considerations for optimizing product capture and purification", Antibodies Vol.1 Production and Purification, Springer Science+Business Media, LLC, (20040101), pages 75 - 100, doi:10.1007/978-1-4419-8875-1, XP093148318
OPPOSITION- Kemp Glenn, Paul O'neil , "Large-scale production of therapeutic antibodies : considerations for optimizing product capture and purification", Kemp Glenn, Paul O'neil , G Subramanian, Antibodies Vol.1 Production and Purification, Springer Science+Business Media, LLC, (20040101), pages 1 - 30, doi:10.1007/978-1-4419-8875-1, ISBN 978-1-4613-4701-9, XP093148318
OPPOSITION- Kemp Glenn, Paul O'neil , "Large-scale production of therapeutic antibodies : considerations for optimizing product capture and purification", Kemp Glenn, Paul O'neil , G. Subramanian, Antibodies Vol.1 Production and Purification, Springer Science+Business Media, LLC, (20040101), pages 75 - 100, doi:10.1007/978-1-4419-8875-1, XP093148318
OPPOSITION- Sung Kwan Yoon ; Yong-Ho Ahn ; Myeong Hyeon Jeong, "Effect of culture temperature on follicle-stimulating hormone production by Chinese hamster ovary cells in a perfusion bioreactor", Applied Microbiology and Biotechnology, Springer, Berlin, DE, Berlin, DE , (20070503), vol. 76, no. 1, doi:10.1007/s00253-007-0985-x, ISSN 1432-0614, pages 83 - 89, XP019538802
OPPOSITION- B. Fischer, "Renaturation of recombinant proteins produced as inclusion bodies", Biotech Adv., (19940101), vol. 12, doi:10.1016/0734-9750(94)90292-5, pages 89 - 101, XP055690584
OPPOSITION- Birch, "Antibody production", Advanced Drug Delivery Reviews, (2006), vol. 58, doi:10.1016/j.addr.2005.12.006, XP024892148
OPPOSITION- Birch, J.R. Racher, A.J., "Antibody production", Advanced Drug Delivery Reviews, Amsterdam , NL , (20060807), vol. 58, no. 5-6, doi:10.1016/j.addr.2005.12.006, ISSN 0169-409X, pages 671 - 685, XP005611421
OPPOSITION- Birch, J.R. Racher, A.J., "Antibody production", Advanced Drug Delivery Reviews, Elsevier, Amsterdam , NL, Amsterdam , NL , (20060807), vol. 58, no. 5-6, doi:10.1016/j.addr.2005.12.006, ISSN 0169-409X, pages 671 - 685, XP005611421
OPPOSITION- Birch, J.R. ; Racher, A.J., "Antibody production", Advanced Drug Delivery Reviews, Elsevier, Amsterdam , NL, Amsterdam , NL , (20060807), vol. 58, no. 5-6, doi:10.1016/j.addr.2005.12.006, ISSN 0169-409X, pages 671 - 685, XP024892148
OPPOSITION- Urig, S. Becker, K., "On the potential of thioredoxin reductase inhibitors for cancer therapy", SEMINARS IN CANCER BIOLOGY., SAUNDERS SCIENTIFIC PUBLICATIONS, PHILADELPHIA, PA., US, US , (20061123), vol. 16, no. 6, doi:10.1016/j.semcancer.2006.09.004, ISSN 1044-579X, pages 452 - 465, XP005727270
OPPOSITION- POWIS G ET AL, "Thioredoxin redox control of cell growth and death and the effects of inhibitors", CHEMICO-BIOLOGICAL INTERACTIONS., ELSEVIER SCIENCE IRLAND., IR, IR , (19980424), vol. 111-112, doi:10.1016/S0009-2797(97)00148-8, ISSN 0009-2797, pages 23 - 34, XP002519386
OPPOSITION- Rubartelli Anna, A Bajetto, G Allavena, E Wollman, R Sitia, "Secretion of Thioredoxin by Normal and Neoplastic Cells through a Leaderless Secretory Pathway*", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (19921205), vol. 267, no. 34, doi:10.1016/S0021-9258(18)35742-9, ISSN 0021-9258, pages 24161 - 24164, XP093146721
OPPOSITION- Rubartelli Anna, A Bajetto, G Allavena, E Wollman, R Sitia, "Secretion of Thioredoxin by Normal and Neoplastic Cells through a Leaderless Secretory Pathway*", Journal of Biological Chemistry, US , (19921205), vol. 267, no. 34, doi:10.1016/S0021-9258(18)35742-9, ISSN 0021-9258, pages 24161 - 24164, XP093146721
OPPOSITION- A Holmgren, "Reduction of disulfides by thioredoxin. Exceptional reactivity of insulin and suggested functions of thioredoxin in mechanism of hormone action", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (19790925), vol. 254, no. 18, doi:10.1016/S0021-9258(19)86818-7, ISSN 0021-9258, pages 9113 - 9119, XP055515419
OPPOSITION- A Holmgren, "Reduction of disulfides by thioredoxin. Exceptional reactivity of insulin and suggested functions of thioredoxin in mechanism of hormone action", Journal of Biological Chemistry, US , (19790925), vol. 254, no. 18, doi:10.1016/S0021-9258(19)86818-7, ISSN 0021-9258, pages 9113 - 9119, XP055515419
OPPOSITION- Jens G. Litske Petersen, Keith J. Dorrington, "An in Vitro System for Studying the Kinetics of Interchain Disulfide Bond Formation in Immunoglobulin G", Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, US, US , (19740910), vol. 249, no. 17, doi:10.1016/S0021-9258(20)79774-7, ISSN 0021-9258, pages 5633 - 5641, XP055690586
OPPOSITION- Magnusson C G , Bjoernstedt M , Holmgren A, "Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses.", Molecular Immunology, GB , (19970701), vol. 34, no. 10, doi:10.1016/S0161-5890(97)00092-8, ISSN 0161-5890, pages 709 - 717, XP002497450
OPPOSITION- MAGNUSSON C G , BJOERNSTEDT M, HOLMGREN A, "Human IgG is substrate for the thioredoxin system: differential cleavage pattern of interchain disulfide bridges in IgG subclasses.", Molecular Immunology, PERGAMON, GB, GB , (19970701), vol. 34, no. 10, doi:10.1016/S0161-5890(97)00092-8, ISSN 0161-5890, pages 709 - 717, XP002497450
OPPOSITION- NORDBERG J, ARNER E S J, "Reactive oxygen species, antioxidants, and the mammalian thioredoxin system.", Free Radical Biology & Medicine, Elsevier Inc, US, US , (20011201), vol. 31, no. 11, doi:10.1016/S0891-5849(01)00724-9, ISSN 0891-5849, pages 1287 - 1312, XP002519388
OPPOSITION- Wei Zhang; Marta J. Czupryn, "Free Sulfhydryl in Recombinant Monoclonal Antibodies", Biotechnology Progress, American Chemical Society, Hoboken, USA, Hoboken, USA, (20080905), vol. 18, no. 3, doi:10.1021/bp025511z, ISSN 8756-7938, pages 509 - 513, XP072297313
OPPOSITION- Wei Zhang; Marta J. Czupryn, "Free Sulfhydryl in Recombinant Monoclonal Antibodies", Biotechnology Progress, Hoboken, USA, (20080905), vol. 18, no. 3, doi:10.1021/bp025511z, ISSN 8756-7938, pages 509 - 513, XP072297313
OPPOSITION- ZHANG WEI, CZUPRYN M J, "Free sulfhydryl in recombinant monoclonal antibodies", Biotechnology Progress, American Chemical Society, Hoboken, USA, Hoboken, USA, (20020501), vol. 18, no. 3, doi:10.1021/BP025511Z, ISSN 8756-7938, pages 509 - 513, XP002500112
OPPOSITION- Wendy B. Chaderjian; Edward T. Chin; Reed J. Harris; Tina M. Etcheverry, "Effect of Copper Sulfate on Performance of a Serum‐Free CHO Cell Culture Process and the Level of Free Thiol in the Recombinant Antibody Expressed", Biotechnology Progress, American Chemical Society, Hoboken, USA, Hoboken, USA, (20080905), vol. 21, no. 2, doi:10.1021/bp0497029, ISSN 8756-7938, pages 550 - 553, XP072297065
OPPOSITION- Wendy B. Chaderjian; Edward T. Chin; Reed J. Harris; Tina M. Etcheverry, "Effect of Copper Sulfate on Performance of a Serum‐Free CHO Cell Culture Process and the Level of Free Thiol in the Recombinant Antibody Expressed", Biotechnology Progress, Hoboken, USA, (20080905), vol. 21, no. 2, doi:10.1021/bp0497029, ISSN 8756-7938, pages 550 - 553, XP072297065
OPPOSITION- CHADERJIAN WENDY B, ET AL, "Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed", Biotechnology Progress, American Chemical Society, Hoboken, USA, Hoboken, USA, (20050301), vol. 21, no. 2, doi:10.1021/BP0497029, ISSN 8756-7938, pages 550 - 553, XP002500111
OPPOSITION- D.J. Roush, Y. Lu, "Advances in Primary Recovery: Centrifugation and Membrane Technology", Biotechnology Progress, American Chemical Society, Hoboken, USA, Hoboken, USA, (20080606), vol. 24, no. 3, doi:10.1021/bp070414x, ISSN 8756-7938, pages 488 - 495, XP055090116
OPPOSITION- J S Wall, "Disulfide Bonds: Determination, Location, and Influence on Molecular Properties of Proteins", Journal of Agricultural and Food Chemistry, American Chemical Society, US, US , (19710701), vol. 19, no. 4, doi:10.1021/jf60176a003, ISSN 0021-8561, pages 619 - 625, XP055514799
OPPOSITION- I Kerblat , C Drouet , S Chesne , P N Marche, "Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys‐proteases", Cancer research, GB , (20011225), vol. 97, no. 1, doi:10.1046/j.1365-2567.1999.00748.x, ISSN 0019-2805, pages 62 - 68, XP071273457
OPPOSITION- KERBLAT; DROUET; CHESNE; MARCHE, "Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys‐proteases", Cancer research, Wiley-Blackwell Publishing Ltd., GB, GB , (20011225), vol. 97, no. 1, doi:10.1046/j.1365-2567.1999.00748.x, ISSN 0019-2805, pages 62 - 68, XP071273457
OPPOSITION- Sears, "A kinetic study in vitro of the reoxidation of interchain disulfide bonds in a human immunoglobulin IgG1", Proc. Nat. Acad. Sci., (1975), vol. 72, doi:10.1073/pnas.72.1.353, XP002630673
OPPOSITION- LYDERSEN B K, BREHM-GIBSON T, MUREL A, "Acid precipitation of mammalian cell fermentation broth.", Annals of the New York Academy of Sciences, New York Academy of Sciences., US, US , (19941130), vol. 745, doi:10.1111/j.1749-6632.1994.tb44375.x, ISSN 0077-8923, pages 222 - 231, XP009033271
OPPOSITION- POWIS G , MONTFORT W R, "Properties and biological activities of thioredoxins", ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY., ANNUAL REVIEW INC., PALO ALTO, CA., US, US , (20010101), vol. 41, doi:10.1146/annurev.pharmtox.41.1.261, ISSN 0362-1642, pages 261 - 295, XP002519387
OPPOSITION- Tanudji Marcel, Hevi Sarah, Chuck Steven L., "The nonclassic secretion of thioredoxin is not sensitive to redox state", American journal of physiology cell physiology, American Physiological Society, US, US , (20030501), vol. 284, no. 5, doi:10.1152/ajpcell.00521.2002, ISSN 0363-6143, pages C1272 - C1279, XP093146727
OPPOSITION- Tanudji Marcel, Hevi Sarah, Chuck Steven L., "The nonclassic secretion of thioredoxin is not sensitive to redox state", American journal of physiology cell physiology, US , (20030501), vol. 284, no. 5, doi:10.1152/ajpcell.00521.2002, ISSN 0363-6143, pages C1272 - C1279, XP093146727
OPPOSITION- BOBOVNIKOVA Y ET AL, "Characterization of soluble, disulfide bond-stabilized, prokaryotically depressed human thyrotropin receptor ectodomain", Endocrinology, The Endocrine Society, US, US , (19970101), vol. 138, no. 2, doi:10.1210/en.138.2.588, ISSN 0013-7227, pages 588 - 593, XP002519385
OPPOSITION- Katariina M Hutterer, Robert W Hong, Jonathon Lull, Xiaoyang Zhao, Tian Wang, Rex Pei, M Eleanor Le, Oleg Borisov, Rob Piper, Yaoqing Diana Liu, Krista Petty, Izydor Apostol, Gregory C Flynn, "Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.", mAbs, Landes Bioscience, US, US , (20130101), vol. 5, no. 4, doi:10.4161/mabs.2475, ISSN 1942-0862, pages 608 - 613, XP055514733
OPPOSITION- Katariina M Hutterer, Robert W Hong, Jonathon Lull, Xiaoyang Zhao, Tian Wang, Rex Pei, M Eleanor Le, Oleg Borisov, Rob Piper, Yaoqing Diana Liu, Krista Petty, Izydor Apostol, Gregory C Flynn, "Monoclonal antibody disulfide reduction during manufacturing: Untangling process effects from product effects.", mAbs, US , (20130101), vol. 5, no. 4, doi:10.4161/mabs.2475, ISSN 1942-0862, pages 608 - 613, XP055514733
OTHER- R K Finn, "AGITATION-AERATION IN THE LABORATORY AND IN INDUSTRY", Finn Bacteriol Rev., (19540101), vol. 18, pages 254 - 274, XP055515363-
OTHER- WONG et al., "Targeting early apoptotic genes in batch and fed-batch CHO cell cultures", Biotechnol Bioeng, (20061020), vol. 95, no. 3, pages 350 - 361, XP055854119
OTHER- Birch, J.R. ; Racher, A.J., "Antibody production", Advanced Drug Delivery Reviews, Elsevier, Amsterdam , NL, Amsterdam , NL, (20060807), vol. 58, no. 5-6, doi:10.1016/j.addr.2005.12.006, ISSN 0169-409X, pages 671 - 685, XP024892148
SEARCH[ ] - TREXLER-SCHMIDT M ET AL, "Identification and prevention of antibody disulfide bond reduction during cell culture manufacturing", BIOTECHNOLOGY AND BIOENGINEERING 20100615 JOHN WILEY AND SONS INC. USA, (20100615), vol. 106, no. 3, doi:10.1002/BIT.22699, pages 452 - 461, XP002694206 [ ] * the whole document *
SEARCH[ ] - KAO YUNG-HSIANG ET AL, "Mechanism of Antibody Reduction in Cell Culture Production Processes", BIOTECHNOLOGY AND BIOENGINEERING, (201011), vol. 107, no. 4, pages 622 - 632, XP002694207 [ ] * the whole document *
SEARCH- GROMER STEPHAN ET AL, "The thioredoxin system: From science to clinic.", MEDICINAL RESEARCH REVIEWS, (200401), vol. 24, no. 1, ISSN 0198-6325, pages 40 - 89, XP002694209 [A] 1-14 * the whole document *
SEARCH- TEILUM K ET AL, "Disulfide Bond Formation and Folding of Plant Peroxidases Expressed as Inclusion Body Protein inEscherichia coliThioredoxin Reductase Negative Strains", PROTEIN EXPRESSION AND PURIFICATION, ACADEMIC PRESS, SAN DIEGO, CA, (19990201), vol. 15, no. 1, ISSN 1046-5928, pages 77 - 82, XP004441744 [A] 1-14 * abstract * * page 77, right-hand column, last sentence of last full paragraph. *
SEARCH- URIG S ET AL, "On the potential of thioredoxin reductase inhibitors for cancer therapy", SEMINARS IN CANCER BIOLOGY, SAUNDERS SCIENTIFIC PUBLICATIONS, PHILADELPHIA, PA, US, vol. 16, no. 6, ISSN 1044-579X, (20061201), pages 452 - 465, (20061201), XP024908082 [A] 1-14 * the whole document *
SEARCH- POWIS G ET AL, "Thioredoxin redox control of cell growth and death and the effects of inhibitors", CHEMICO-BIOLOGICAL INTERACTIONS 19980424 IE, (19980424), vol. 111-112, ISSN 0009-2797, pages 23 - 34, XP002519386 [A] 1-14 * the whole document *
SEARCH- NORDBERG J ET AL, "Reactive oxygen species, antioxidants, and the mammalian thioredoxin system.", FREE RADICAL BIOLOGY & MEDICINE 1 DEC 2001, (20011201), vol. 31, no. 11, ISSN 0891-5849, pages 1287 - 1312, XP002519388 [A] 1-14 * the whole document *
SEARCH- ZHANG WEI ET AL, "Free sulfhydryl in recombinant monoclonal antibodies", BIOTECHNOLOGY PROGRESS, (200205), vol. 18, no. 3, ISSN 8756-7938, pages 509 - 513, XP002500112 [A] 1-14
SEARCH- CHADERJIAN WENDY B ET AL, "Effect of copper sulfate on performance of a serum-free CHO cell culture process and the level of free thiol in the recombinant antibody expressed", BIOTECHNOLOGY PROGRESS, (200503), vol. 21, no. 2, ISSN 8756-7938, pages 550 - 553, XP002500111 [DA] 1-14 * the whole document *
SEARCH- D.J. ROUSH ET AL, "Advances in Primary Recovery: Centrifugation and Membrane Technology", BIOTECHNOLOGY PROGRESS, (20080415), vol. 24, no. 3, doi:10.1021/bp070414x, ISSN 8756-7938, pages 488 - 495, XP055090116 [PA] 1-14 * the whole document *
SEARCH- KERBLAT I ET AL, "Importance of thioredoxin in the proteolysis of an immunoglobulin G as antigen by lysosomal Cys-proteases", IMMUNOLOGY, (199905), vol. 97, no. 1, ISSN 0019-2805, pages 62 - 68, XP002519384 [A] 1-14 * the whole document *
SEARCH- LYDERSEN B K ET AL, "Acid precipitation of mammalian cell fermentation broth", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, US, (19941130), vol. 745, doi:10.1111/J.1749-6632.1994.TB44375.X, ISSN 0077-8923, pages 222 - 231, XP009033271 [A] 1-14 * the whole document *
SEARCH- POWIS G ET AL, "Properties and biological activities of thioredoxins", ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY 2001 US, (2001), vol. 41, ISSN 0362-1642, pages 261 - 295, XP002519387 [A] 1-14 * the whole document *
SEARCH- BOBOVNIKOVA Y ET AL, "Characterization of soluble, disulfide bond-stabilized, prokaryotically depressed human thyrotropin receptor ectodomain", ENDOCRINOLOGY, (1997), vol. 138, no. 2, ISSN 0013-7227, pages 588 - 593, XP002519385 [A] 1-14 * abstract * * page 588, column R, paragraphs 1-6 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents